Seers
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Seers makes wearable heart-monitoring devices and AI-powered software that help doctors detect irregular heart rhythms, a condition called arrhythmia, in patients.
Hospitals, clinics, and health-screening centres across South Korea use its two services: mobiCARE™ for outpatient ECG analysis and thynC™ for real-time vital-sign monitoring of admitted patients. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company's core business model is a subscription-based service through which medical institutions access its devices and AI analysis platform without large upfront equipment costs.
Summary is AI-generated and may contain errors · figures from DART filings
Its subscription model is structured to fit within South Korea's national health-insurance reimbursement framework, which governs how diagnostic tests are billed and paid for domestically.
Seers in five facts
What does Seers do?
Seers makes wearable heart-monitoring devices and AI-powered software that help doctors detect irregular heart rhythms, a condition called arrhythmia, in patients.
Where is Seers listed and in which sector?
Seers (Korean name: 씨어스) trades under KRX code 458870 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Seers?
Its market capitalisation was US$665.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Seers's latest annual revenue and operating profit?
For fiscal year 2025, Seers reported revenue of US$36.4M, operating profit of US$12.3M and net income of US$12.1M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 494.7% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Securities issuance results (voluntary)Oct 21
- Material event report (convertible bonds)
Seers disclosed convertible bonds to raise US$82.5M, about 11.9% of its market value.
Capital raise · Oct 13 - Investor relations (IR) meetingSep 9
- Ex-rights (bonus issue)Capital raise · Mar 23
- Trading suspension (bonus issue)Capital raise · Mar 10
- Material event report (bonus issue)Capital raise · Mar 10
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Seers reported consolidated results for FY2025: revenue of US$33.3M (+494.7% year on year), operating profit of US$11.3M (from a loss a year earlier) and net income of US$11.2M (from a loss a year earlier).
Earnings · Feb 4
